| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800026 | 注射用重组人鼠嵌合抗CD30单克隆抗体-MCC-DM1偶联剂 | B-006 | Lyophilized | Biological Products(1) | New Drug Application | 2018-03-09 | 上海复旦张江生物医药股份有限公司 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd | Certificate Issued | 2018-07-13 | view |